Skip to main content
Journal cover image

What happens when cardiac Na channel function is compromised? 2. Numerical studies of the vulnerable period in tissue altered by drugs.

Publication ,  Journal Article
Starmer, CF; Grant, AO; Colatsky, TJ
Published in: Cardiovasc Res
March 15, 2003

OBJECTIVE: The fate of an impulse arising from stimulation is determined by the ability of the wave front to recruit sufficient Na channels from adjacent cells. Previous numerical studies of mutant Na channels revealed both the velocity of a conditioning wave and the recruiting capacity of the front as determinants of the vulnerable period (VP), an interval within which excitation results in unidirectional conduction. Drugs that block excitatory Na channels in a voltage dependent manner, such as antiarrhythmics, abused substances and antidepressants, slow the restoration of Na conductance trailing an action potential and are associated with proarrhythmia and sudden cardiac death. We hypothesized that drug-induced slowing of Na conductance recovery would flatten the Na conductance restoration gradient thereby reducing the recruiting capacity of a front, extending the VP and increasing the probability of unidirectional propagation. METHODS: In a cable of ventricular cells, we explored the sensitivity of the VP to voltage-dependent blockade. While varying the unbinding time constant from 100 ms to 5 s, we measured the Na conductance restoration gradient, the liminal length, the refractory period (RP) and the VP. RESULTS: Reducing the rate of drug unbinding flattened the restoration gradient, diminished the recruiting capacity of a premature impulse and extended the liminal length, RP and the VP. The VP was linearly dependent on the drug unbinding time constant. Rapidly unbinding drugs (time constant <1 s) reduced the liminal length below that of a quiescent cable. CONCLUSIONS: Slowing the unbinding rate of voltage-dependent drug block of Na channels extended the RP and the VP. Drugs with unbinding time constants greater than 1 s dramatically increased the probability of unidirectional propagation, reflecting increases in both the RP and the VP. This study provides a new mechanism linking Na channel function, compromised by voltage-dependent Na channel drug block, with proarrhythmic conditions that can lead to sudden cardiac death following premature stimulation.

Duke Scholars

Published In

Cardiovasc Res

DOI

ISSN

0008-6363

Publication Date

March 15, 2003

Volume

57

Issue

4

Start / End Page

1062 / 1071

Location

England

Related Subject Headings

  • Sodium Channels
  • Sodium Channel Blockers
  • Refractory Period, Electrophysiological
  • Models, Cardiovascular
  • Humans
  • Heart Conduction System
  • Computer Simulation
  • Cardiovascular System & Hematology
  • Anti-Arrhythmia Agents
  • Action Potentials
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Starmer, C. F., Grant, A. O., & Colatsky, T. J. (2003). What happens when cardiac Na channel function is compromised? 2. Numerical studies of the vulnerable period in tissue altered by drugs. Cardiovasc Res, 57(4), 1062–1071. https://doi.org/10.1016/s0008-6363(02)00727-7
Starmer, C Frank, A. O. Grant, and T. J. Colatsky. “What happens when cardiac Na channel function is compromised? 2. Numerical studies of the vulnerable period in tissue altered by drugs.Cardiovasc Res 57, no. 4 (March 15, 2003): 1062–71. https://doi.org/10.1016/s0008-6363(02)00727-7.
Starmer, C. Frank, et al. “What happens when cardiac Na channel function is compromised? 2. Numerical studies of the vulnerable period in tissue altered by drugs.Cardiovasc Res, vol. 57, no. 4, Mar. 2003, pp. 1062–71. Pubmed, doi:10.1016/s0008-6363(02)00727-7.
Journal cover image

Published In

Cardiovasc Res

DOI

ISSN

0008-6363

Publication Date

March 15, 2003

Volume

57

Issue

4

Start / End Page

1062 / 1071

Location

England

Related Subject Headings

  • Sodium Channels
  • Sodium Channel Blockers
  • Refractory Period, Electrophysiological
  • Models, Cardiovascular
  • Humans
  • Heart Conduction System
  • Computer Simulation
  • Cardiovascular System & Hematology
  • Anti-Arrhythmia Agents
  • Action Potentials